News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amylin Pharmaceuticals, Inc. (AMLN) Said to Attract Interest From Pfizer Inc. (PFE), AstraZeneca PLC (AZN), Sanofi (France) (SAN.PA)


5/15/2012 7:32:11 AM

Amylin Pharmaceuticals Inc. (AMLN) has lured suitors such as Pfizer Inc. (PFE), AstraZeneca Plc (AZN) and Sanofi, which signed confidentiality agreements on the drugmaker’s sale process, said people familiar with the matter. Merck & Co., Takeda Pharmaceutical Co., Roche Holding AG (ROG) and Bristol-Myers Squibb Co. (BMY) also signed agreements to get access to confidential financial and product information for Amylin, said the people, who declined to be identified as talks are private. The drug developer is seeking a buyer following its rejection of an unsolicited offer from Bristol-Myers, people with knowledge of the matter said earlier this year.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES